HYAL2 Methylation in Peripheral Blood as a Potential Marker for the Detection of Pancreatic Cancer – A Case Control Study

Oncotarget - United States
doi 10.18632/oncotarget.18757
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

hTERT Promoter Methylation Status in Peripheral Blood Leukocytes as a Molecular Marker of Head and Neck Cancer Progression

Journal of Applied Genetics
MedicineGenetics
2018English

Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection

PLoS ONE
Multidisciplinary
2011English

Promoter Methylation of TRIM9 as a Marker for Detection of Circulating Tumor DNA in Breast Cancer Patients

SpringerPlus
Multidisciplinary
2015English

A Genetic Variant Rs1801274 in FCGR2A as a Potential Risk Marker for Kawasaki Disease: A Case-Control Study and Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Pilot Study of Blood Biomarker Candidates for Detection of Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2010English

KRAS Mutations in Blood Circulating Cell-Free DNA: A Pancreatic Cancer Case-Control

Oncotarget
Oncology
2016English

Zonulin as Marker of Pregnancy Induced Hypertension: A Case Control Study

Clinical Hypertension
2020English

Methylation Analysis for Postpartum Depression: A Case Control Study

BMC Psychiatry
PsychiatryMental Health
2019English

Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy